Episode 621: Aducanumab is not effective for mild cognitive impairment or mild Alzheimer's dementia and has major safety issues

POEM of the Week Podcast - Un podcast de Mark Ebell and Michael Wilkes

Essayez BookBeat gratuitement pendant 60 jours

Profitez d'un univers entier d'audiolivres et d'e-books, allant des nouveautés aux classiques.

Sponsored

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' Aducanumab is not effective for mild cognitive impairment or mild Alzheimer's dementia and has major safety issues '

Visit the podcast's native language site